COMRAD - comparative radiation hybrid mapping
 
introduction
background
participants
maps and markers
projects
Roslin Institute

 

Markers

BTA 23

Framework markers
Marker ID
Primer 1
Primer 2
Retention Frequency
Gene Name
 
AP2B*
GCAGTGTGCTCCCATCTCTT
TCATGGAGCCAGAGAGGTGA
0.096
 
F1
BAK1BCL2
TATGCACAGGGGAACTGTGA
TGGGGGTTGCAGTTTATTTT
0.398
 
F2
BM1258
GTATGTATTTTTCCCACCCTGC
GAGTCAGACATGACTGAGCCTG
0.319
 
F3
BM1443
AATAAAGAGACATGGTCACCGG
TCGAGGTGTGGGAGGAAG
0.266
 
F2
BM1815
AGAGGATGATGGCCTCCTG
CAAGGAGACAAGTCAAGTTCCC
0.266
 
 
BM1818
AGCTGGGAATATAACCAAAGG
AGTGCTTTCAAGGTCCATGC
0.185
 
F3
BM1905
GTCCATGGGTTCACAAAGAG
ACGCCTGCTGATGCTGTAG
0.202
 
F1
BM47
ACAGGAAGGAGAAGGGGAAG
CCGGGGTCACATGACTCTG
0.287
 
F3
BMS2269
AATTCACCCACTGCCAGC
TGAAATATGCTTACCTCCCACC
0.202
 
 
BMS2275
GGGGATATCGAGAGGATGTG
ATCCTCCAGCCTACACCTAGC
0.16
 
F3
BMS4036
GCTCCCAATAAGAAGGTCCC
GGATCGAGACTTAAGAACACGC
0.16
 
F2
BMS468
GTTAAGCAGAGGGTTTCCCC
TATTCCCAGGTGCTCTGAGG
0.266
 
 
Bola-A*
GATGAAGCATCACTCAGTCCC
GGCTCTGATGTGTCTCTCACG
0.287
Bovine lymphocyte antigen A
 
BOLADRBP*
ATCCTCTCTCTGCAGCACATTTCCT
CGCGCTCACCTCGCCGCTG
0.191
Bovine lymphocyte antigen DR beta subunit
F3
BP34
ATTTGAAAAGGCCTGTGAGG
TAGCTTGACTCCAACCTCTTCC
0.213
 
 
BTN*
GAGGCATTTTCAGGCATCAT
GTGGGAGCCTGGATAAGACA
0.192
butyrophilin
 
C4*
GGAGGGTTACCGGATGAAAT
ATCCAGCTGTTCGAGTCCAG
0.333
complement component 4
 
CI0BT528B
TGCTTCTGTAAATGACGTTCCG
AACTCCAGGAGTTGGTGATGG
0.298
 
 
CMAH*
AGGCTGCCTATGAAGGTTGA
CACTTCAGGCAGTGGAAACA
0.138
cytidine monophosphate-N-acetylneuraminic acid hydroxylase
F3
CSSM024
GAGGATGCAGAACCAGGCGTTAGA
GGTCGAAGAGAGTCAGACATGACT
0.255
 
 
CYP21*
GGAGGGTTACAGTCCATGAGTTTG
TCGCGATCCAACTCCTCCTGAAG
0.298
cytochrome P450, subfamily XXI [steroid 21-hydroxylase]
 
CYP21A2*
GGAGGGTTACAGTCCATGAGTTT
TCGCGATCCAACTCCTCCTGAAG
0.33
cytochrome P450, subfamily XXI [steroid 21-hydroxylase]
F1
DMA*
CACACAATGTACTGCCAGGA
CAGTGTGAACACCTGAACGA
0.33
major histocompatibility complex, class II, DM alpha-chain, expressed
 
DRB3*
GAGAGTTTCACTGTGCAG
CCAGAGTGAGTGAAGTATCTCT
0.202
major histocompatibility complex, class II, DR beta 3
F3
F13A1*
CAAGGAGAGGTGGGATAGCA
AGATCCCTTGTGGGGTCATA
0.351
coagulation factor XIII, A1 polypeptide [blood coagulation factor XIII A1 subunit]
 
GSTA2*
CCTCCCATGGATGAGAAAAT
TCTGAAACACATTCTAGGAGGAGA
0.163
glutathione S-transferase A2
 
HSPA1*
GGATTGCTCATGTTTGTTATGG
CTTGGAAGTAAACAGAAACGGG
0.247
heat shock 70 kD protein 1
 
HSPA1B*
CAAGATCACCATCACCAACG
CAGCTCCTTCCTCTTGTGCT
0.298
heat shock 70 kD protein 2
F1
INRA064
GCCCACAGCGCTCTCTAC
CTGAAAGCAGAATGAGGTGC
0.33
 
 
INRA132
AACATTTCAGCTGATGGTGGC
TTCTGTTTTGAGTGGTAAGCTG
0.312
 
F1
LMP7*
GAATGGTTCTGTAGGATCTC
CCTTCTCTCTAATCTCAAGC
0.362
proteasome subunit, beta type 8 [prosome, macropain] [large multifunctional protease 7]
 
MCM3*
TGGTCTGCATCGATGAGTTT
CCAATGGCAGTAGCAAGATG
0.223
???
 
MOG*
CAGCTGCTAAAAGAGACCATTG
TTTCAATTCCATCGCTGCCTCC
0.217
myelin oligodendrocyte glycoprotein
F1
PIM1*
GATCCACTCTGGAGGGCTAT
CTGCTCAAGGACACCGTCTA
0.29
pim-1 oncogene
 
POU5F1POU
TCGGACACAACTGAAGCAAC
TGAGCCAGATCAGTCCTGTG
0.287
 
F2
RM033
GCTCATTCTCCTGGGATGCAGA
GCTCCTTTAGTTTTCTTGTGGGAG
0.181
 
F2
TNF*
CAGGCATAAACCAGGATGTCC
GCGGCAGTGGCAGCGTGGCAG
0.266
tumor necrosis factor, alpha [cachectin]
 
TNFA*
TCTCAAGCCTCAAGTAACAAGC
ATGAGGTAAAGCCCGTCAGC
0.293
tumor necrosis factor, alpha [cachectin]
 
TNFe*
AGAAGACAGAGGCAGGTCCA
AAGAATCCCTTCTCCCTCCA
0.266
???
 
TNH*
   
0.223
 
F2
UWCA1
AGAGTGTCTTATAATTAGCCAGGAAG
AACTCTTTCAGTTGGTTCCTGT
0.298
 
F2
VEGF*
GATGTGACAAGCCGAGGC
GGATTCAGGATTGTTCTGTCG
0.266
vascular endothelial growth factor
Not included in map
 
CSH1*
AGCCCTGTTGAGGTTGGTTA
CGAATCCCTGTGTAGGCAGT
0.181
placental lactogen
 
CSNK2B*
CGGTTTCAAGATCCATCCAATG
TTCCCACCACAATAACGACTCC
0.356
casein kinase 2, beta polypeptide
 
MLN*
CAGCAGAGGTCAGAGGAGGT
GGGAGAGGGTGTTTTCCTTC
0.348
motilin
 
PRL*
GGAAAGTGAACATGACTGTCTAG
GCCCTCTCTTCTACAATGAACAC
0.191
prolactin
 
RDS*
CTGCATCCAGTACCAGCTCA
AGAAAGGCCTTCCAGGTCTC
0.483
retinal degeneration, slow [human : retinitis pigmentosa 7]
 
RM002
AGCAATGTCAAACATTGCTCC
TCCATCTTTACAACTTTTGAATC
0.086
 
 
SFRS3*
TGGAACAGTGACACAAAGGTG
TTTCCAGCTGGCTTTTGAGT
0.407
splicing factor, arginine/serine-rich 3

back to main choice

© Roslin Institute 2002

Dr John Williams
0131 527 4200